Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

U.S. Patent And Trademark Office Issues Lisata Therapeutics Composition Of Matter Patent For Certepetide Through March 2040 With Opportunity For Patent Term Extension

Author: Benzinga Newsdesk | July 15, 2025 07:11am

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension

This patent covers novel cyclic peptides and their use in treating solid tumors

Posted In: LSTA